BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31725845)

  • 21. Use of detailed family history data to improve risk prediction,with application to breast cancer screening.
    Jiang Y; Weinberg CR; Sandler DP; Zhao S
    PLoS One; 2019; 14(12):e0226407. PubMed ID: 31846476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implementation of screening colonoscopy amongst first- degree relatives of patients with colorectal cancer in Turkey: a cross-sectional questionnaire based survey.
    Adakan Y; Taskoparan M; Cekin AH; Duman A; Harmandar F; Taskin V; Yilmaz U; Yesil B
    Asian Pac J Cancer Prev; 2014; 15(14):5523-8. PubMed ID: 25081658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk-Adapted Starting Age of Personalized Lung Cancer Screening: A Population-Based, Prospective Cohort Study in China.
    Wang C; Dong X; Tan F; Wu Z; Huang Y; Zheng Y; Luo Z; Xu Y; Zhao L; Li J; Zou K; Cao W; Wang F; Ren J; Shi J; Chen W; He J; Li N
    Chest; 2024 Jun; 165(6):1538-1554. PubMed ID: 38253312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Age at initiation of screening mammography by family history of breast cancer in the breast cancer surveillance consortium.
    Durham DD; Roberts MC; Khan CP; Abraham LA; Smith RA; Kerlikowske K; Miglioretti DL
    Cancer Causes Control; 2021 Jan; 32(1):103-107. PubMed ID: 33098534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comprehensive evaluation of family history and breast cancer risk. The Utah Population Database.
    Slattery ML; Kerber RA
    JAMA; 1993 Oct; 270(13):1563-8. PubMed ID: 8371466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Performance of Screening Ultrasonography as an Adjunct to Screening Mammography in Women Across the Spectrum of Breast Cancer Risk.
    Lee JM; Arao RF; Sprague BL; Kerlikowske K; Lehman CD; Smith RA; Henderson LM; Rauscher GH; Miglioretti DL
    JAMA Intern Med; 2019 May; 179(5):658-667. PubMed ID: 30882843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Personalized Initial Screening Age for Colorectal Cancer in Individuals at Average Risk.
    Chen X; Heisser T; Cardoso R; Hoffmeister M; Brenner H
    JAMA Netw Open; 2023 Oct; 6(10):e2339670. PubMed ID: 37878311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.
    Saadatmand S; Tilanus-Linthorst MM; Rutgers EJ; Hoogerbrugge N; Oosterwijk JC; Tollenaar RA; Hooning M; Loo CE; Obdeijn IM; Heijnsdijk EA; de Koning HJ
    J Natl Cancer Inst; 2013 Sep; 105(17):1314-21. PubMed ID: 23940285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BRCA1 mutations and breast cancer in the general population: analyses in women before age 35 years and in women before age 45 years with first-degree family history.
    Malone KE; Daling JR; Thompson JD; O'Brien CA; Francisco LV; Ostrander EA
    JAMA; 1998 Mar; 279(12):922-9. PubMed ID: 9544766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perceptions of Prostate Cancer Screening Controversy and Informed Decision Making: Implications for Development of a Targeted Decision Aid for Unaffected Male First-Degree Relatives.
    Gwede CK; Davis SN; Wilson S; Patel M; Vadaparampil ST; Meade CD; Rivers BM; Yu D; Torres-Roca J; Heysek R; Spiess PE; Pow-Sang J; Jacobsen P
    Am J Health Promot; 2015; 29(6):393-401. PubMed ID: 24968183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Promoting cancer screening among the first-degree relatives of breast and colorectal cancer patients: the design of two randomized trials.
    Marcus AC; Ahnen D; Cutter G; Calonge N; Russell S; Sedlacek SM; Wood M; Manchester D; Fox L; McCaskill-Stevens W; Fairclough D; Hines S; Wenzel L; Osborn K
    Prev Med; 1999 Mar; 28(3):229-42. PubMed ID: 10072740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accuracy of cancer family histories: comparison of two breast cancer syndromes.
    Schneider KA; DiGianni LM; Patenaude AF; Klar N; Stopfer JE; Calzone KA; Li FP; Weber BL; Garber JE
    Genet Test; 2004; 8(3):222-8. PubMed ID: 15727243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective colonoscopic study to investigate risk of colorectal neoplasms in first-degree relatives of patients with non-advanced adenomas.
    Ng SC; Kyaw MH; Suen BY; Tse YK; Wong MCS; Hui AJ; Tak HY; Lau JYW; Sung JJY; Chan FKL
    Gut; 2020 Feb; 69(2):304-310. PubMed ID: 31028155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Family History on Relative and Absolute Risks for Colorectal Cancer: A Systematic Review and Meta-Analysis.
    Roos VH; Mangas-Sanjuan C; Rodriguez-Girondo M; Medina-Prado L; Steyerberg EW; Bossuyt PMM; Dekker E; Jover R; van Leerdam ME
    Clin Gastroenterol Hepatol; 2019 Dec; 17(13):2657-2667.e9. PubMed ID: 31525516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of Benign Breast Diseases and Association With Age, Hormonal Factors, and Family History of Breast Cancer Among Women in Sweden.
    Johansson A; Christakou AE; Iftimi A; Eriksson M; Tapia J; Skoog L; Benz CC; Rodriguez-Wallberg KA; Hall P; Czene K; Lindström LS
    JAMA Netw Open; 2021 Jun; 4(6):e2114716. PubMed ID: 34170304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Family history and risk of breast cancer: an analysis accounting for family structure.
    Brewer HR; Jones ME; Schoemaker MJ; Ashworth A; Swerdlow AJ
    Breast Cancer Res Treat; 2017 Aug; 165(1):193-200. PubMed ID: 28578505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breast cancer screening, outside the population-screening program, of women from breast cancer families without proven BRCA1/BRCA2 mutations: a simulation study.
    Jacobi CE; Nagelkerke NJ; van Houwelingen JH; de Bock GH
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):429-36. PubMed ID: 16537697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of breast cancer family history on tumor detection and tumor size in women newly-diagnosed with invasive breast cancer.
    Schwab FD; Bürki N; Huang DJ; Heinzelmann-Schwarz V; Schmid SM; Vetter M; Schötzau A; Güth U
    Fam Cancer; 2014 Mar; 13(1):99-107. PubMed ID: 24002368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of Digital Breast Tomosynthesis vs Digital Mammography With Cancer Detection and Recall Rates by Age and Breast Density.
    Conant EF; Barlow WE; Herschorn SD; Weaver DL; Beaber EF; Tosteson ANA; Haas JS; Lowry KP; Stout NK; Trentham-Dietz A; diFlorio-Alexander RM; Li CI; Schnall MD; Onega T; Sprague BL;
    JAMA Oncol; 2019 May; 5(5):635-642. PubMed ID: 30816931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.